Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15024101 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed dnaJ Peptide for Relieving Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: dnaJ peptide;   Drug: None-placebo

Indicates status has not been verified in more than two years